August 9, 2017
Sponsored by Catalent
Our state-of-the-art biologics manufacturing facility (which uses single-use systems) is expanding to add 22,000 ft2 of space and with that, the flexibility and scale to support your growth. The expansion adds a new 2 × 2,000-L single-use bioreactor system to support late-phase clinical and commercial-scale production of up to 4,000-L batches, as well as expansion of analytical and process development laboratories. Catalent offers a broad range of integrated process development and analytical services to solve your most difficult development and biologics clinical and commercial manufacturing challenges, including
Flexible CGMP and non-CGMP single-use manufacturing (10–4,000-L batch scale)
Colocated analytical laboratory to support method development, in-process, release, and stability testing
Tailored process development and process characterization capabilities
Solutions for difficult-to-express proteins
Expanded GPEx® cell line engineering capacity
Tech transfer of externally developed cell lines and/or processes
Biosimilar development programs
Login to read the full PDF of the application note.
You May Also Like
